Bolognesi Claudia, Knasmueller Siegfried, Nersesyan Armen, Roggieri Paola, Ceppi Marcello, Bruzzone Marco, Blaszczyk Ewa, Mielzynska-Svach Danuta, Milic Mirta, Bonassi Stefano, Benedetti Danieli, Da Silva Juliana, Toledo Raphael, Salvadori Daisy Maria Fávero, Groot de Restrepo Helena, Filipic Metka, Hercog Klara, Aktas Ayça, Burgaz Sema, Kundi Michael, Grummt Tamara, Thomas Philip, Hor Maryam, Escudero-Fung Maria, Holland Nina, Fenech Michael
Environmental Carcinogenesis Unit, IRCCS AOU San Martino-IST, L.go Rosanna Benzi, 10 16132 Genoa, Italy.
Department of Chemical Safety and Cancer Prevention, Institute of Cancer Research, Medical University of Vienna, Austria Borschkegasse 8A, 1090 Vienna, Austria.
Mutagenesis. 2017 Mar 1;32(2):257-266. doi: 10.1093/mutage/gew047.
The buccal micronucleus cytome (BMNcyt) assay in uncultured exfoliated epithelial cells from oral mucosa is widely applied in biomonitoring human exposures to genotoxic agents and is also proposed as a suitable test for prescreening and follow-up of precancerous oral lesions. The main limitation of the assay is the large variability observed in the baseline values of micronuclei (MNi) and other nuclear anomalies mainly related to different scoring criteria. The aim of this international collaborative study, involving laboratories with different level of experience, was to evaluate the inter- and intra-laboratory variations in the BMNcyt parameters, using recently implemented guidelines, in scoring cells from the same pooled samples obtained from healthy subjects (control group) and from cancer patients undergoing radiotherapy (treated group). The results indicate that all laboratories correctly discriminated samples from the two groups by a significant increase of micronucleus (MN) and nuclear bud (NBUD) frequencies and differentiated binucleated (BN) cells, associated with the exposure to ionizing radiation. The experience of the laboratories was shown to play an important role in the identification of the different cell types and nuclear anomalies. MN frequency in differentiated mononucleated (MONO) and BN cells showed the greatest consistency among the laboratories and low variability was also detected in the frequencies of MONO and BN cells. A larger variability was observed in classifying the different cell types, indicating the subjectivity in the interpretation of some of the scoring criteria while reproducibility of the results between scoring sessions was very good. An inter-laboratory calibration exercise is strongly recommended before starting studies with BMNcyt assay involving multiple research centers.
口腔黏膜未培养的脱落上皮细胞颊黏膜微核细胞组(BMNcyt)检测法在生物监测人类暴露于遗传毒性剂方面被广泛应用,并且也被提议作为口腔癌前病变预筛查和随访的合适检测方法。该检测法的主要局限性在于,在微核(MNi)和其他主要与不同评分标准相关的核异常的基线值中观察到较大的变异性。这项国际合作研究的目的是,利用最近实施的指南,评估BMNcyt参数在实验室间和实验室内的变异情况,这些参数来自从健康受试者(对照组)和接受放疗的癌症患者(治疗组)获得的相同混合样本中的细胞评分。结果表明,所有实验室通过微核(MN)和核芽(NBUD)频率的显著增加以及与电离辐射暴露相关的双核(BN)细胞的区分,正确地区分了两组样本。实验室的经验在识别不同细胞类型和核异常方面发挥了重要作用。分化的单核(MONO)细胞和BN细胞中的MN频率在各实验室之间表现出最大的一致性,并且在MONO细胞和BN细胞的频率中也检测到低变异性。在分类不同细胞类型时观察到较大的变异性,这表明在解释某些评分标准时存在主观性,而评分过程之间结果的可重复性非常好。强烈建议在开始涉及多个研究中心的BMNcyt检测研究之前进行实验室间校准练习。